Litcius/Paper detail

TRIM21 promotes ubiquitination of SARS‐CoV‐2 nucleocapsid protein to regulate innate immunity

Shenglan Mao, Xue-Fei Cai, Siqiang Niu, Jie Wei, Ning Jiang, Haijun Deng, Wen Wang, Jing Zhang, Shimei Shen, Yuanyan Ma, Xiaoli Wu, Qiling Peng, Ailong Huang, Deqiang Wang

2023Journal of Medical Virology22 citationsDOIOpen Access PDF

Abstract

Abstract The innate immune response is the first line of host defense against viral infections, but its role in immunity against SARS‐CoV‐2 remains unclear. By using immunoprecipitation coupled with mass spectroscopy, we observed that the E3 ubiquitin ligase TRIM21 interacted with the SARS‐CoV‐2 nucleocapsid (N) protein and ubiquitinated it at Lys 375 . Upon determining the topology of the TRIM21‐mediated polyubiquitination chain on N protein, we then found that polyubiquitination led to tagging of the N protein for degradation by the host cell proteasome. Furthermore, TRIM21 also ubiquitinated the N proteins of SARS‐CoV‐2 variants of concern, including Alpha, Beta, Gamma, Delta , and Omicron together with SARS‐CoV and MERS‐CoV variants. Herein, we propose that ubiquitylation and degradation of the SARS‐CoV‐2 N protein inhibited SARS‐CoV‐2 viral particle assembly, by which it probably involved in preventing cytokine storm. Eventually, our study has fully revealed the association between the host innate immune system and SARS‐CoV‐2 N protein, which may aid in developing novel SARS‐CoV‐2 treatment strategies.

Topics & Concepts

Innate immune systemUbiquitinUbiquitin ligaseImmunoprecipitationVirologyBiologyCytokine stormProteasomeProtein degradationCell biologyImmunityImmune systemChemistryAntibodyImmunologyCoronavirus disease 2019 (COVID-19)BiochemistryMedicineGenePathologyInfectious disease (medical specialty)Diseaseinterferon and immune responsesMosquito-borne diseases and controlSARS-CoV-2 and COVID-19 Research